Moodle
You are not logged in. (Login)
Skip Check this out...
Show or hide block

Check this out...

Welcome to E-Menai

risks of taking ambien and alcohol The product is currently marketed by Novartis Pharma AG, via a license from APR, under the trademarks Voltfast or Catafast in several European countries. A privately held company, KPA focuses its efforts on the acquisition, development, licensing and marketing of pharmaceutical products.kowapharma. About Applied Pharma Research APR Applied Pharma Research SA is an independent, international, vertically integrated drug delivery and drug development company in healthcare with registered offices in Switzerland and the U.apr. King's wholly-owned subsidiary, Alpharma, Inc.

.


NewsA Level

"The approval is the culmination of over three years of effort from our partners at Applied Pharma Research and the internal team at Kowa," said William Maichle, Chief Operating Officer of Kowa Pharmaceuticals America, Inc. About Applied Pharma Research APR Applied Pharma Research SA is an independent, international, vertically integrated drug delivery and drug development company in healthcare with registered offices in Switzerland and the U. and BRISTOL, Tenn. Food and Drug Administration (FDA) has issued a Complete Response Letter regarding the New Drug Application (NDA) for Acurox (oxycodone HCl, USP and niacin, USP) Tablets CII, an immediate release product intended for the relief of moderate-to-severe pain. Acura and King are currently evaluating the FDA's Complete Response Letter, and at this stage believe they can respond to the issues raised without conducting any additional studies..